"Aldevron's scientists then tested Cytogenix's synDNA tm vaccine's activity in a rabbit model using a proprietary technology developed by Aldevron. Cytogenix's synDNA tm vaccine generated an antibody response that was up to five times greater than levels generated from a comparable plasmid DNA vaccine produced by bacterial fermentation."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.